Genesis Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.16M Sell
16,380
-250
-2% -$58.3K 2.49% 14
2026
Q1
$4.07M Hold
16,630
2.71% 14
2025
Q4
$3.44M Sell
16,630
-1,000
-6% -$198K 2.36% 14
2025
Q3
$3.27M Hold
17,630
2.3% 14
2025
Q2
$2.69M Hold
17,630
2.02% 14
2025
Q1
$2.92M Hold
17,630
2.37% 15
2024
Q4
$2.55M Buy
+17,630
New +$2.73M 2.22% 16
2015
Q2
$1.84M Buy
18,897
+272
+1% +$27.2K 1.5% 18
2015
Q1
$1.85M Sell
18,625
-600
-3% -$61K 1.53% 18
2014
Q4
$1.95M Buy
+19,225
New +$2.03M 1.54% 15

Other funds holding JNJ

Genesis Wealth Advisors's JNJ Position: Q2 2026 in Review

Genesis Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, selling an estimated $58.3K and leaving 16,380 shares worth $4.16M. The position accounts for 2.49% of the portfolio, ranked #14.

Genesis Wealth Advisors first reported a position in JNJ in Q4 2014 and has held it in 10 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Genesis Wealth Advisors held 16,380 shares of Johnson & Johnson worth $4.16M as of Q2 2026.
  • Genesis Wealth Advisors sold 250 Johnson & Johnson shares in Q2 2026, an estimated $58.3K.
  • Johnson & Johnson made up 2.49% of Genesis Wealth Advisors's portfolio in Q2 2026, its #14 holding.
  • Genesis Wealth Advisors first reported a position in Johnson & Johnson in Q4 2014 and has held it in 10 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Genesis Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.